ID   GM04022
AC   CVCL_1H81
DR   CLO; CLO_0016242
DR   Coriell; GM04022
DR   Wikidata; Q54838369
RX   CelloPub=CLPUB00447;
RX   PubMed=25928884;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H82 ! GM04023
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 14
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In misc. document) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda; USA (1992).
//
RX   PubMed=25928884; DOI=10.1186/s13024-015-0018-7; PMCID=PMC4411791;
RA   Evers M.M., Schut M.H., Pepers B.A., Atalar M., van Belzen M.J.,
RA   Faull R.L.M., Roos R.A.C., van Roon-Mom W.M.C.;
RT   "Making (anti-) sense out of huntingtin levels in Huntington
RT   disease.";
RL   Mol. Neurodegener. 10:21.1-21.11(2015).
//